Abstract
R-GEM-Lenalidomide Versus R-GEM-P As Second-Line Treatment of Diffuse Large B-Cell Lymphoma: Results from the UK NCRI Phase II Randomized Legend Trial
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have